REFERENCES
- Centers for Disease Control and Prevention. Prescription drug overdoses—a U.S. Epidemic. MMWR Morb Mort Wkly Rep. 2012;61:10–13.
- Substance Abuse and Mental Health Services Administration Web site. 2014. Available at: http://www.samhsa. gov/prescription-drug-misuse-abuse. Accessed December 2, 2014.
- Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1564–1574.
- Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15:556–562.
- Birnbaum HG, White AG, Reynolds JL, et al. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Clin J Pain. 2006;22: 667–676.
- White AG, Birnbaum HG, Mareva MN, et al. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005;11:469–479.
- Haynes R. Forming research questions. In: Haynes R, Sacket D, Guyatt G, Tugwell P, eds. Clinical Epidemiology: How to do Clinical Practice Research. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:3–14.
- Critical Appraisal Skills Programme Web site. http://www.casp-uk.net/#!casp-tools-checklists/c18f8. Accessed December 1, 2014.
- Baser O, Xie L, Mardekian J, Schaaf D, Wang L, Joshi AV. Prevalence of diagnosed opioid abuse and its economic burden in the Veterans Health Administration. Pain Pract. 2014;14:437–445.
- Bazalo GR, Joshi AV, Weiss RC, Harnett J, Galaznik A, Sullivan SD. Potential impact of immediate release opioid analgesics with tamper resistant technologies on abuse treatment and drug acquisition costs. Value Health. 2013:16:A115.
- Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12:657–667.
- Chandwani HS, Strassels SA, Rascati KL, Lawson KA, Wilson JP. Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events. J Pain Palliat Care Pharmacother. 2013;27:206–213.
- Hansen RN, Oster G, Edelsberg J, Woody GE, Sullivan SD. Economic costs of nonmedical use of prescription opioids. Clin J Pain. 2011;27:194–202.
- Inocencio TJ, Carroll NV, Read EJ, Holdford DA. The economic burden of opioid-related poisoning in the United States. Pain Med. 2013;14:1534–1547.
- McAdam-Marx C, Roland CL, Cleveland J, Oderda GM. Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliat Care Pharmacother. 2010;24:5–18.
- Pasquale MK, Joshi AV, Dufour R, et al. Cost drivers of prescription opioid abuse in commercial and medicare populations. Pain Pract. 2014;14:E116–E125.
- Rice JB, Kirson NY, Shei A, et al. Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Appl Health Econ Health Policy. 2014;12:435–446. doi: 10.1007/s40258-014-0102-0.
- Rice JB, Kirson NY, Shei A, et al. The economic burden of diagnosed opioid abuse among commercially insured individuals. Postgrad Med. 2014;126:53–58. doi: 10.3810/pgm.2014.07.2783.
- Rice J, Bodnar K, Shei A, Birnbaum H, Holly P, Ben-Joseph R. Differences between high-cost and low-cost patients diagnosed with opioid abuse. Value Health. 2014;17:A214–A215.
- Roland, CL, Joshi, AV, Mardekian J, Walden SC, Harnett, J. Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States. J Opioid Manage. 2013:9:161–175.
- Rossiter LF, Kirson NY, Shei A, et al. Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US. J Med Econ. 2014;17:279–287.
- Tkacz J, Pesa J, Vo L, et al. Opioid analgesic-treated chronic pain patients at risk for problematic use. Am J Manag Care. 2013;19:871–880.
- White AG, Birnbaum H, Schiller M, Waldman T, Cleveland MS, Roland CL. Economic impact of opioid abuse dependence and misuse. Am J Pharm Benefits. 2011;3:e59–e70.
- Xie L, Joshi AV, Schaaf D, et al. Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit. Pain Pract. 2014;14:446–456.